Qivalis Gets Dutch EMI License for a MiCA Euro Stablecoin
A consortium of 37 major European banks is now one regulatory step away from issuing a euro-denominated electronic money token (EMT) on a public blockchain. De Nederlandsche Bank (DNB) has granted Qivalis an Electronic Money Institution (EMI) license, making the Amsterdam-based company the first bank-backed issuer to reach this stage under the EU's Markets in Crypto-Assets (MiCA) framework. For accounting firms, CFOs, and finance teams holding or settling in stablecoins, the development redraws the risk and compliance landscape for euro-denominated digital assets.
What Qivalis Is and How It Got Here
Qivalis was founded in September 2025 as a consortium vehicle backed by some of Europe's largest financial institutions, including BBVA, BNP Paribas, ING, and DZ Bank. The company's stated purpose is to provide banks and payment companies with a way to transfer euros using blockchain technology, distributing its token through existing financial infrastructure rather than directly to retail consumers.
The DNB license and what comes next
The DNB authorization classifies Qivalis as an Electronic Money Institution, the legal category that MiCA requires for any entity issuing a euro-pegged EMT. Obtaining the license is a necessary precondition, not the finish line. Qivalis has confirmed that it still needs to satisfy the remaining MiCA requirements, most notably publishing a compliant white paper, before it can lawfully offer the token to the public in the EU. The company expects to complete those steps and begin distribution within the coming months.
The scale of the consortium, 37 banks, gives Qivalis a distribution network that no single-institution issuer could replicate at launch. The company has not yet disclosed which member banks will actively use the token at go-live, nor has it published volume projections.
MiCA's EMT Rules: The Regulatory Architecture Behind the License
Understanding why the DNB license matters requires a close reading of MiCA's stablecoin taxonomy. MiCA distinguishes between two categories of stablecoin: asset-referenced tokens (ARTs) and electronic money tokens. All EMTs are stablecoins under MiCA, but not every stablecoin qualifies as an EMT.
What makes a token an EMT under MiCA
An EMT must be pegged to a single official currency, in Qivalis's case the euro. It must be issued exclusively by an authorized credit institution or a licensed EMI. Those two requirements together give the holder a direct legal claim against the issuer and an unconditional right to redeem at face value at any time. That redemption right is not discretionary; it is embedded in the MiCA text and enforceable across all EU member states.
One constraint that CFOs and treasury teams should note immediately: EMTs cannot pay interest under MiCA. The regulation was deliberately drafted to prevent EMTs from functioning as deposit substitutes that could destabilize conventional bank funding. Any yield mechanism layered on top of a MiCA-compliant EMT would breach the framework.
Where dollar-pegged stablecoins fit
Dollar-backed tokens, including USDC, can also qualify as EMTs if their issuer obtains the appropriate authorization and the token meets all MiCA conditions. Issuers that do not satisfy those requirements cannot lawfully offer their tokens to the public in the EU, regardless of their global market position. That creates a meaningful regulatory distinction between tokens that carry the full MiCA redemption guarantee and those that do not, a distinction that must be reflected in how finance teams classify and account for each instrument.
Stablecoin Accounting Treatment Under MiCA EMT Classification
The EMT structure has direct consequences for how Qivalis tokens, and any MiCA-compliant EMT, should be recorded in corporate books. Stablecoin accounting under IFRS remains an area of active standard-setter attention, but the MiCA legal architecture provides some useful anchors.
The redemption right as an accounting anchor
Because an EMT holder has an unconditional contractual right to redeem at face value, the instrument has a legal profile closer to a financial asset than to a speculative crypto asset. Under IAS 32, a contractual right to receive cash (or its equivalent) from another entity is a financial asset. A MiCA-compliant EMT pegged to the euro and redeemable at par sits squarely within that definition, which matters enormously for balance sheet classification, measurement, and disclosure.
Firms currently using fair value through profit or loss (FVTPL) for non-MiCA stablecoins may find that a MiCA EMT warrants a different classification, potentially amortised cost if the token is held to collect and cash flows are solely payments of principal, though the absence of a fixed maturity complicates that analysis. Finance teams should document their accounting policy choice before the first token appears on the balance sheet.
No-interest rule and treasury policy
The prohibition on interest-bearing EMTs shapes treasury strategy. A CFO holding Qivalis tokens as a settlement buffer cannot earn a yield on that balance within the token itself. That is a direct cost compared with money market funds or short-duration instruments. Treasury policy documents should reflect this constraint and set out the approved use cases, intraday liquidity management, cross-border settlement, and DeFi collateral, where the EMT delivers operational value even without yield.
Implications for crypto accounting software workflows
Finance teams using digital asset accounting software or crypto bookkeeping software will need to ensure their systems can distinguish MiCA-classified EMTs from unregulated stablecoins. The classification affects not only the P&L line but also VAT treatment, financial instrument disclosures, and, where relevant, prudential capital calculations for regulated entities. Ledger entries for EMT receipts and payments should capture the MiCA classification at the point of recording, not retrospectively. This is exactly the kind of structured tagging that robust crypto accounting software must support as the EMT market matures.
Practical Implications for Accounting Firms and Audit Teams
The Qivalis license creates a concrete near-term scenario that audit and advisory practices need to prepare for. Once the token launches, clients in the Netherlands and across the EU may begin using it for treasury settlement, payroll in euros, or supply-chain payments between consortium member banks.
Client disclosure and going-concern considerations
Auditors reviewing financial statements that include EMT balances will need to assess whether the client has properly disclosed the nature of the instrument, the counterparty risk concentrated in the Qivalis EMI entity, and any concentration risk arising from holding significant balances in a token distributed through a newly licensed issuer. The DNB license provides regulatory legitimacy, but it does not eliminate issuer-specific operational risk in the early months of a launch.
AML and KYC obligations for onboarding EMT flows
Accounting firms advising clients who receive or transmit Qivalis EMTs will also need to consider Travel Rule obligations. Under MiCA and the accompanying Transfer of Funds Regulation (TFR), crypto asset service providers must collect and transmit originator and beneficiary data for token transfers. A MiCA EMT is not exempt from TFR simply because it carries a redemption guarantee. Firms should verify that clients' crypto asset service providers are TFR-compliant before any significant volume flows begin. For context on how the EU has been tightening licensing standards more broadly, the cross-border stablecoin risks flagged by the FSB remain relevant background reading for any compliance review.
What This Means for the Broader European Stablecoin Market
Qivalis is not operating in a vacuum. The European stablecoin space is moving fast, with institutional players testing both euro-pegged and dollar-pegged EMTs. The consortium model Qivalis has adopted is specifically designed to solve the chicken-and-egg problem that has slowed earlier euro stablecoin efforts: no liquidity without distribution, no distribution without liquidity. By anchoring 37 banks at the outset, Qivalis enters the market with a credible settlement network from day one.
Competitive and structural dynamics
The arrival of a bank-backed, MiCA-compliant euro EMT will put pressure on existing euro stablecoin offerings to clarify their own regulatory status. Firms that have been accepting or holding euro stablecoins under informal arrangements should treat the Qivalis launch as a prompt to audit their current holdings and confirm which tokens in their treasury carry enforceable MiCA redemption rights and which do not. The distinction has legal, accounting, and counterparty risk consequences that cannot be deferred indefinitely.
The institutional appetite for regulated onchain settlement is also visible elsewhere: Standard Chartered's institutional RLUSD stablecoin custody arrangement on the XRP Ledger illustrates how large banks are moving from observation to active participation across multiple jurisdictions and token types.
What Qivalis still needs to disclose
The company has yet to publish its MiCA white paper, confirm which of its 37 member banks will actively participate at launch, or share expected transaction volumes. Those gaps matter for firms doing due diligence. A white paper, once published, will be the primary source of information on reserve composition, redemption mechanics, and governance. Finance teams should monitor its publication and review it against their own accounting policy and treasury risk framework before onboarding the token.
Key MiCA EMT Requirements at a Glance
The table below summarises the core MiCA conditions that apply to any euro-denominated EMT, based on the regulation's published text.
| Requirement | MiCA Rule | Accounting / Treasury Implication |
|---|---|---|
| Issuer must be an authorized credit institution or licensed EMI | Title III, MiCA | Counterparty risk is regulated; relevant for financial instrument classification |
| Peg to a single official currency | Title III, MiCA | Par-value redemption right supports amortised cost analysis under IAS 32 |
| Unconditional right to redeem at face value at any time | Title III, MiCA | Limits fair-value volatility; may reduce FVTPL designation necessity |
| No interest payments permitted | Title III, MiCA | Treasury must plan for zero yield on EMT balances; affects cash-management policy |
| White paper publication required before public offer | Title III, MiCA | Key diligence document for auditors and treasury teams before onboarding |
Frequently Asked Questions
Is a MiCA EMT the same as a CBDC?
No. A central bank digital currency (CBDC) is a liability of a central bank. A MiCA EMT is a liability of a licensed private institution, in this case Qivalis as an EMI. Holders have a legal claim on the issuer, not on the central bank. The DNB oversees Qivalis as its supervisor but does not stand behind the token in the way it would behind a sovereign digital currency.
How should a euro EMT appear on a corporate balance sheet under IFRS?
The unconditional right to redeem at par means the token meets the IAS 32 definition of a financial asset: a contractual right to receive cash from the issuer. Classification between amortised cost and FVTPL depends on the entity's business model and whether the contractual cash flow characteristics test is satisfied. Given the absence of a fixed maturity, finance teams should document their policy carefully and consult with their auditors before the first balance sheet date on which EMT holdings appear.
Does the no-interest rule affect how Qivalis tokens are taxed?
Tax treatment of EMTs varies by member state and is not fully harmonised under MiCA itself. The absence of interest eliminates one category of taxable income, but firms may still encounter tax events on disposal, exchange, or use in settlement depending on local rules. Finance teams in the Netherlands should review the Dutch tax authority's (Belastingdienst) guidance on digital assets and confirm the treatment with their tax adviser before volume positions are taken.
What AML checks apply when receiving a Qivalis EMT payment?
The Transfer of Funds Regulation requires crypto asset service providers involved in EMT transfers to collect, verify, and transmit originator and beneficiary information, mirroring the SWIFT messaging obligations in traditional payments. Corporate treasury teams receiving EMT payments via a CASP should confirm that the CASP is TFR-compliant and that transaction records are retained in a format that satisfies their own AML record-keeping obligations.
When can firms expect to use the Qivalis token in practice?
Qivalis has indicated that it intends to publish its MiCA white paper and complete remaining regulatory steps within the coming months. Until the white paper is published and distribution partners are confirmed, the token cannot be lawfully offered in the EU. Finance teams should treat this as a monitoring item rather than an immediate action point, and schedule a policy review for when the white paper becomes available.
Source: CoinDesk Policy